Scimed v. ACS
This article was originally published in The Gray Sheet
Executive Summary
Lilly subsidiary Advanced Cardiovascular Systems' motion to stay litigation filed by Scimed is granted by U.S. District Court for the Northern District of California. Litigation proceedings in the case are postponed indefinitely, according to ACS. Scimed had filed suit May 31, alleging that ACS' Flowtrack 40 and Rx Elipse percutaneous transluminal coronary angioplasty catheters infringe two of its patents ("The Gray Sheet" June 6, In Brief). ACS' motion to stay argued that a settlement agreement reached between the two companies in August 1991 applied to this case. The settlement, according to ACS, included an arbitration provision and a covenant not to sue